Liposomal Anthracyclin in the Treatment of Elderly ALL
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
Phase II multicentric study comparing VAD regimen with continuous infusion over 96 hours of
doxorubicin, vincristine and dexamethasone to a 90 minutes infusion of equivalent doses of
Dox li-PEG, bolus infusion of vincristine and dexamethasone